Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
14M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
75.3K
-
Shares change
-
-16K
-
Total reported value, excl. options
-
$147K
-
Value change
-
-$47K
-
Number of buys
-
5
-
Number of sells
-
-3
-
Price
-
$1.95
Significant Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) as of Q1 2025
10 filings reported holding MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share as of Q1 2025.
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.3K shares
of 14M outstanding shares and own 0.54% of the company stock.
Largest 10 shareholders include Ackerman Capital Advisors, LLC (34.5K shares), GEODE CAPITAL MANAGEMENT, LLC (19.6K shares), UBS Group AG (7.51K shares), Federation des caisses Desjardins du Quebec (7.1K shares), OSAIC HOLDINGS, INC. (2.89K shares), Steward Partners Investment Advisory, LLC (2.09K shares), Tower Research Capital LLC (TRC) (1.64K shares), BANK OF AMERICA CORP /DE/ (15 shares), HRT FINANCIAL LP (0 shares), and Virtu Financial LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.